The NO Regular Defibrillation testing In Cardioverter Defibrillator Implantation (NORDIC ICD) trial: concept and design of a randomized, controlled trial of intra-operative defibrillation testing during de novo defibrillator implantation.

Dietmar Bänsch, Hendrik Bonnemeier, Johan Brandt, Frank Bode, Jesper Hastrup Svendsen, Angelika Felk, Tino Hauser, Karl Wegscheider

Research output: Contribution to journalArticlepeer-review

11 Citations (SciVal)

Abstract

Although defibrillation (DF) testing is still considered a standard procedure during implantable cardioverter-defibrillator (ICD) insertion and has been an essential element of all trials that demonstrated the survival benefit of ICD therapy, there are no large randomized clinical trials demonstrating that DF testing improves clinical outcome and if the outcome would remain the same by omitting DF testing.
Original languageEnglish
Pages (from-to)142-147
JournalEuropace
Volume17
Issue number1
DOIs
Publication statusPublished - 2015

Subject classification (UKÄ)

  • Cardiac and Cardiovascular Systems

Fingerprint

Dive into the research topics of 'The NO Regular Defibrillation testing In Cardioverter Defibrillator Implantation (NORDIC ICD) trial: concept and design of a randomized, controlled trial of intra-operative defibrillation testing during de novo defibrillator implantation.'. Together they form a unique fingerprint.

Cite this